SYSTEMIC DIAGNOSTICS // FIDUCIARY ARCHIVE
THE FIDUCIARY REGISTRY
Independent, non-smoothable intelligence logs and systemic diagnostics compiled over more than a decade of tracing transaction metadata. This archive operates as a sovereign database built to strip away narrative seduction, exposing where portfolio assets are weaponised as pawns within private equity's opaque black box. It equips Level 1 allocators with the precise metrics required to enforce baseline accountability and cleanly separate authentic operational execution from debt-engineered luck.
Real-Time Diagnosis: The €880M Golden Goose Bond Sale & The Corporate Doom Loop
Less than 24 hours after publishing a warning on the “Corporate Doom Loop”, Golden Goose announced an €880M bond sale. This real-time diagnosis breaks down the mathematics of the buyout, revealing how a €57M annual interest burden collides with a 64% Asset Inefficiency Score (AIS). See the clinical proof of how Private Equity debt structures inevitably cannibalise fundamentally decaying assets.
On Tuesday, 14 April 2026, I published a Strategic Advisory Brief detailing the “Corporate Doom Loop”—the 20% bankruptcy trap created when Private Equity layers debt onto fundamentally decaying assets. I used a highly publicised €2.5 billion acquisition as the primary diagnostic case study.
Less than 24 hours later, Bloomberg and the global financial press announced that Golden Goose is marketing an €880 million bond sale to fund that exact acquisition by HSG. The market is measuring the Euribor spread. They are entirely blind to the survival rate.
Inspired by Professor Ludovic Phalippou (Oxford Saïd), whose recent viral post demonstrated how an LLM could decode complex private equity debt structures in seconds, I decided to test the predictive power of my framework in real time.
This morning, I fed my Strategic Advisory Brief and the live market data into ChatGPT, asking it to diagnose the event: How can Golden Goose support its new €880M debt structure under the HSG buyout?
The LLM’s response was a clinical dissection of the “Corporate Doom Loop” playing out in real time:
“They cannot support it without cannibalising the host.”
Running the mathematics on this €880M debt reveals a reality far more severe than a simple 6% interest rate. Here is the clinical breakdown of the burden, and exactly who extracts the value.
1. The Real Mathematics of the €880M Debt
Golden Goose closed 2025 with €734M in revenue and ~€248M in Adjusted EBITDA. Consider the debt funding the HSG buyout:
Floating Rate Tranche: 3-month Euribor (currently ~2.2%) plus 400–425 basis points, yielding ~6.2% to 6.45%.
Fixed Rate Tranche: Yielding in the mid-to-high 6% range.
Blended across the €880M issuance, Golden Goose is saddled with €55M to €57M in pure annual interest.
2. The Collision: Debt vs. The 64% Inefficiency Score
GPs and credit rating agencies justify this debt against the €248M Adjusted EBITDA, assuming stable revenue. The Organisational CT Scan dismantles this assumption.
Diagnostic data shows Golden Goose operates with a 64% Asset Inefficiency Score (AIS). Approximately €469M of its 2025 revenue was transacted with customers carrying a 91% probability of churn due to unaddressed structural friction.
When a customer base bleeds at this velocity, immense marketing capital is spent merely to replace those fleeing. Yet, product innovation is starved because €57M is immediately extracted for bondholders. The CEO must cut costs—cheapening materials or raising prices (see my recent diagnosis of how this exact “Value Engineering” destroyed the 153-year-old Russell & Bromley). This accelerates the ‘Network Jump’ of customer friction, driving churn higher. This is the 20% bankruptcy loop in motion.
3. Who Actually Wins?
Golden Goose will not win; brand equity is hollowed out to service the yield.
There are three winners:
The Exiting GP (Permira): Cashed out LPs at a €2.5B valuation before operational decay destroys the EBITDA.
The Investment Banks: Syndicating the debt to extract millions in upfront fees, transferring long-term risk to bond buyers.
The Acquiring GP (HSG): Extracting management fees whilst using debt to minimise equity at risk.
The losers include employees facing cost-cutting, customers buying degrading products, and Limited Partners (LPs) holding debt against a decaying asset.
Financial markets measure the Euribor spread; I measure the survival rate.
“To see the invisible, we simply need new rulers.”—Morten J. Sørensen
THE STRATEGIC ADVISORY BRIEF
To read the complete mathematical methodology behind this diagnosis, including how Limited Partners can demand Asset Inefficiency Scores (AIS) to protect their capital, read the full 24-page memorandum published yesterday: